Antioxidant properties of fullerenol C₆₀(OH)₂₄ in rat kidneys, testes, and lungs treated with doxorubicin

References

• Aebi H. 1974. Catalase. In: Bergmayer HU, editor. Methods of enzymatic analysis. New York: Academic Press. pp 673–677.
   Google Scholar
• Anderson R, Barron RA. 2005. Reaction of hydroxyfullerene with metal salts: a route to remediation and immobilization. J Am Chem Soc 127:10458–10459.
   PubMedGoogle Scholar
• Andrievsky GV, Bruskov VI, Tykhomyrov AA, Gudkov SV. 2009. Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostructures in vitro and in vivo. Free Radic Biol Med 47:786–793.
   PubMed Web of Science ®Google Scholar
• Azambuja E, Fleck JF, Batista RG, Menna Barreto SS. 2005. Bleomycin lung toxicity: who are the patients with increased risk. Pulm Pharmacol Ther 18:363–366.
   PubMed Web of Science ®Google Scholar
• Beutler E. 1984. Red cell metabolism: A manual of biochemical methods. NewYork: Grune&Stratton.
   Google Scholar
• Bihari P, Vippola M, Schultes S, Praetner M, Khandoga AG, Reichel CA, Coester C, Tuomi T, Rehberg M, Krombach F. 2008. Optimized dispersion of nanoparticles for biological in vitro and in vivo studies. Particle Fibre Toxicol 5: 14.
   PubMed Web of Science ®Google Scholar
• Blum J, Fridovic I. 1985. Inactivation of glutathione-peroxidase by superoxide radical. Arch Biochem Biophys 249:500–508.
   Google Scholar
• Bogdanovic G, Kojic V, Djordjevic A, Canadanovic-Brunet M, Vojinovic-Miloradov M, Baltic VV. 2004. Modulating activity of fullerenol C60(OH)22 on doxorubicin-induced cytotoxicity. Toxicol In Vitro 18:629–637.
   PubMed Web of Science ®Google Scholar
• Bogdanović V, Stankov K, Ičević I, Žikić D, Šolajić S, Djordjevic A, Bogdanovic G. 2008. Fullerenol C60(OH)24 effects on antioxidative enzymes activity in irradiated human erythroleukemia cell line. J Radiat Res 49:321–327.
   PubMedGoogle Scholar
• Brant JA, Robichaund CO, Wiesner M. 2007. Fullerol cluster formation in aqueous solutions: implications for environmental release. J Colloid Interf Sci 314:281–288.
   PubMed Web of Science ®Google Scholar
• Cai X, Jia H, Liu Z, Hou B, Luo C, Feng Z, Li W, Liu J. 2008. Polyhydroxylated fullerene derivative C60(OH)24 prevents mitochondrial dysfunction and oxidative demage in an MMP+-induced cellular model of Parkinson’s disease. J Neurosci Res 86:3622–3634.
   PubMed Web of Science ®Google Scholar
• Chaudhuri P, Harfouche R, Soni S, Hentschel S, Sengupta S. 2010. Shape effect of carbon nanovectors on angiogenesis. ACS Nano 4:574–582.
   PubMed Web of Science ®Google Scholar
• Chaudhuri P, Paraskar A, Soni S, Mashelkar RA, Sengupta S. 2009. Fullerenol-cytotoxic conjugates for cancer chemotherapy. ACS Nano 3:2505–2514.
   PubMed Web of Science ®Google Scholar
• Chen YW, Hwang KC, Yen CC, Lai LL. 2004. Fullerene derivates protect against oxidative stress in RAW 264.7 cells and ischemia-reperfused lungs. Am J Physiol Regul Integr Comp Physiol 287:21–26.
   PubMed Web of Science ®Google Scholar
• Djordjevic A, Canadanovic-Brunet J, Vojinovic-Miloradov M, Bogdanovic G. 2005. Antioxidant properties and hypothetical radical mechanism of fullerenol C60(OH)24. Oxi Commun 27:213–218.
   Google Scholar
• Djordjevic A, Vojinović-Miloradov M, Petranović N, Devečerski A, Lazar  D, Ribar B.1998. Catalytic preparation and characterization of C60Br24. Fullerene Sci Technol 6:689–694.
   Google Scholar
• Djordjevic-Milic V, Stankov K, Injac R, Djordjevic A, Srdjenovic B, Govedarica B, Radic N, Simic VD, Strukelj B. 2009. Activity of antioxidative enzymes in erythrocytes after a single dose administration of doxorubicin in rats pretreated with fullerenol C60(OH)24. Toxicol Mech Meth 19:24–28.
   PubMedGoogle Scholar
• Faraji AH, Wipf P. 2009. Nanoparticles in cellular drug delivery, Bioorg Med Chem 17:2950–2962.
   PubMed Web of Science ®Google Scholar
• Foley S, Crowley C, Smaihi M, Bonfils C, Erlanger BF, Seta P, Larroque C. 2002. Cellular localization of a water-soluble fullerene derivative. Biochem Biophys Res Commun 294:116–119.
   PubMed Web of Science ®Google Scholar
• Griffin Green EA, Zaleska MM, Erecsinska M. 1988. Adriamycin induced lipid peroxidation in mitochondria and microsomes. Biochem Pharmacol 37:3071–3077.
   PubMedGoogle Scholar
• Injac R, Boskovic M, Perse M, Koprivec-Furlan E, Cerar A, Djordjevic A, Strukelj B. 2008c. Acute doxorubicin nephrotoxicity in rats with malignant neoplasm can be successfully treated with fullerenol C60(OH)24 via suppresison of oxidative stress. Pharmacol Rep 60:742–749.
   PubMed Web of Science ®Google Scholar
• Injac R, Perse M, Boskovic M, Djordjevic-Milic V, Djordjevic A, Hvala A, Cerar A, Strukelj B. 2008a.. Cardioprotective effects of fullerenol C60(OH)24 on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm. Technol Cancer Res Treat 7:15–25.
   PubMedGoogle Scholar
• Injac R, Perse M, Obermajer N, Djordjevic-Milic V, Prijatelj M, Djordjevic A, Cerar A, Strukelj B. 2009b. Protective effects of fullerenol C60(OH)24 against doxorubicin-induced cardiotoxicity and hepatotoxicity in rats with colorectal cancer. Biomaterials 30:1184–1196.
   PubMed Web of Science ®Google Scholar
• Injac R, Perse M, Obermajer N, Djordjevic-Milic V, Prijatelj M, Djordjevic A, Cerar A, Strukelj B. 2008b. Potential hepatoprotective effects of fullerenol C60(OH)24 in doxorubicin-induced hepatotoxicity in rats with mammary carcinomas. Biomaterials 29:3451–3460.
   PubMed Web of Science ®Google Scholar
• Injac R, Radic N, Govedarica B, Perse M, Cerar A, Djordjevic A, Strukelj B. 2009a. Acute doxorubicin pulmotoxicity in rats with malignant neoplasm is effectively treated with fullerenol C60(OH)24 trough inhibition of oxidative stress. Pharmacol Rep 61:335–342.
   PubMed Web of Science ®Google Scholar
• Janssen YMW, Borm PJA, Van Houten B, Mossman BT. 1993. Cell and tissue responses to oxidative demage. Lab Invest 69:261–274.
   PubMed Web of Science ®Google Scholar
• Kalaiselvi P, Prgasam V, Chinnikishnan S, Veena CK, Sundarapandiyan R, Varalakshmi P. 2005. Counteracting adriamycin-induced oxidative stress by administration of N-acetyl cysteine and vitamin E. Clin Chem Lab Med 43:834–840.
   PubMed Web of Science ®Google Scholar
• Manoury B, Nenan S, Leclerc O, Guenon I, Lagente V, Boichot E, Bertrand CP, Lagente V. 2005. The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res 6:11.
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. 1969. Superoxide dismutase, an enzymic function for erythrocuprein (hemocuprein). J Biol Chem 244:6049–6055.
   PubMed Web of Science ®Google Scholar
• Meadors M, Floyd J, Perry MC. 2006. Pulmonary toxicity of chemotherapy. Semin Oncol 33:98–105.
   PubMed Web of Science ®Google Scholar
• Milic-Torres V, Srdjenovic B, Jacevic V, Dragojevic Simic V, Djordjevic A, Simplício AL. 2010. Fullerenol C60(OH)24 successfully prevents doxorubicin induced acute cardiotoxicity in rats. Pharmacol Rep 62: in press.
   Google Scholar
• Mimnaugh EG, Trush MA, Gram TE. 1986. A possible role of membrane lipid peroxidation in anthracycline nephrotoxicity. Biochem Pharmacol 35:4327–4335.
   PubMed Web of Science ®Google Scholar
• Minotti G. 1993. Sources and role of iron in lipid peroxidation. Chem Res Toxicol 6:134–146.
   PubMed Web of Science ®Google Scholar
• Mirkov S, Djordjevic A, Andric N, Andric S, Kostic T, Bogdanovic G, Vojinovic-Miloradov M, Kovacevic R. 2004. Nitric-oxide scavenging activity of polyhydroxylated fullerenol C60(OH)24. Nitric Oxide Biol Chem 11:201–207.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Koh YH, Park YS, Fujiwara N, Sakiyama H, Misonou Y, Ookawara T, Suzuki K, Honke K, Taniguchi N. 2003. Oxidative stress caused by inactivation of gluthathione peroxidase and adaptive responses. Biol Chem 384:567–574.
   PubMed Web of Science ®Google Scholar
• Mrdjanovic J, Solajic S, Bogdanovic V, Stankov K, Bogdanovic G, Djordjevic A. 2009. Effects of fullerenol C60(OH)24 on the frequency of micronuclei and chromosome aberrations in CHO-K1 cells. Mutat Res Genet Toxicol Environ Mutagen 680:25–30.
   Google Scholar
• Murugan MA, Gangadharan B, Mathur PP. 2002. Antioxidative effect of fullerenol on goat epididymal spermatozoa. Asian J Androl 4:149–152.
   PubMed Web of Science ®Google Scholar
• Öz E, Ilham MN. 2006. Effects of melatonin in reducing the toxic effects of doxorubicin. Mol Cell Biochem 286:11–15.
   PubMed Web of Science ®Google Scholar
• Prahalathan C, Selvacumar E, Varalakshami P. 2005. Protective effect of lipoic acid on adriamycine-induced testicular toxicity. Clin Chim Acta 360:160–166.
   PubMed Web of Science ®Google Scholar
• Sadik NAH, Ismail MF, Shaheen AA. 2008. Effect of probucol and deferoxamine against adriamycin toxicity in cardiac and renal tissues of rats. Indian J Biochem Biophys 45:44–50.
   Google Scholar
• Trajković S, Dobrić S, Jačević V, Dragojević-Simić V, Milovanović Z, Đorđevic A. 2007. Tissue protective effects of fullerenol C60(OH)24 and amifostine in irradiated rats. Colloids Surf B Biointerfaces 58:39–43.
   PubMed Web of Science ®Google Scholar
• Uchiama M, Mihara M. 1978. Determination of malonaldehide precursor in tissues by thiobarbituric acid test. Anal Biochem 8:271–278.
   Google Scholar
• Vileno B, Marcox PR, Lekka M, Sienkiewicz A, Fehre T, Forro L. 2006. Spectroscopic and physical properties of a highly derivatiyed C60 fullerol. Adv Funct Mater 16:120–128.
   Web of Science ®Google Scholar
• Wilson SR, Schuster DI, Nuber B, Meier MS, Maggini M, Prato M, Taylor R. 2000. Organic chemistry of fullerenes. In: Kadish KM, Ruoff RS, editors. Fullerenes: Chemistry, physics and technology. New York: Wiley-Interscience. pp 91–177.
   Google Scholar
• Xia T, Kovochich M, Brant J, Hotze M, Sempf J, Oberley T, Sioutas C, Yeh JI, Wiesner MR, Nel AE. 2006. Comparison of the abilities of ambient and manufactured nanoparticle to induce cellular toxicity according to an oxidative stress paradigm. Nano Lett 6:1794–1807.
   PubMed Web of Science ®Google Scholar
• Yagmurca M, Erdogan H, Iraz M, Songur A, Ucar M, Fadilloglu E. 2004. Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clin Chim Acta 348:27–34.
   PubMed Web of Science ®Google Scholar
• Yamavaki H, Iwai N. 2006. Cytotoxicity of water soluble fullerenol in vascular endothelial cells. Am J Physiol Cell Physiol 290:1495–1502.
   Google Scholar
• Yeh YC, Lai HC, Ting CT, Lee WL, Wang LC, Lai HC, Liu TJ. 2007. Protection by doxycycline against doxorubicin-induced oxidative stress and apoptosis in mouse testes. Biochem Pharmacol 74:969–980.
   PubMed Web of Science ®Google Scholar
• Yin JJ, Lao F, Fu PP, Kanakamma PP, Shen CKF, Luh TY. 2009. The scavenging of reactive oxygen species and the potential for cell protection by functionalized fullerene materials. Biomaterials 30:611–621.
   PubMed Web of Science ®Google Scholar